Search results
Results from the WOW.Com Content Network
Genome Valley is an Indian high-technology business district spread across 2,000-acre (8.1 km 2)/(3.1 sq mi) in Hyderabad, India. [1] [2] It is located across the suburbs, Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and ...
Bharat Biotech has its manufacturing facility situated at Genome Valley, Hyderabad, India. [5] As of July 2020, the company has over 700 employees [6] and has a presence worldwide. [5] The company has been responsible for developing an eco-friendly recombinant [7] and a naturally attenuated strain derived Rotavirus vaccine called ROTAVAC.
Naidu persuaded Bill Gates to establish a Microsoft development center in Hyderabad, making it the only Microsoft development center outside the USA at that time. He also worked diligently to bring biotechnology companies to Hyderabad, developing Genome Valley, a high-end technology park commissioned in 1999 as S. P. Biotech Park.
This is a non-exhaustive list of prominent companies based in Hyderabad, Telangana (i.e. having their headquarters in Hyderabad). Adyar Ananda Bhavan; Aurobindo Pharma [1] Biological E. Limited; Bharat Biotech [2] Brightcom Group; Cyient; Central Institute of Tool Design; Deccan chronicle; Divi's Laboratories [3] Dr. Reddy's Laboratories [4]
The manufacturing facility of Shantha Biotechnics near the Genome Valley. Shantha Biotechnics, Ltd. began with the initiatives of Dr. K. I. Varaprasad Reddy and Khalil Ahmed. Varaprasad and Ahmed established the company in 1993 to produce affordable drugs for the general population, while maintaining international standards in quality. [1]
in 1999, Naidu established the Pharma City, an original, state-of-the-art biotechnology park in the country to the north of Hyderabad and promoted Genome Valley [80] [81] to leading multinational pharmaceutical companies like Novartis Pharma India, Shantha Biotechnics, Bharat Biotech, Biocon, Biological E. Limited, Jupiter Biosciences, and also ...
National Center for Laboratory Animal Sciences, Hyderabad. On 18 November 2015 the union Government of India, approved a long-pending proposal envisaging Rs 338.58 crore-world-class-facility for breeding beagle dogs, horses, and monkeys besides other animals on a large scale to indigenously to meet the needs of the country's pharma firms for drug testing and clinical research.
During the COVID-19 pandemic, the company signed a pact with Baylor College of Medicine, Texas Children's Hospital and Dynavax Technologies to develop a COVID-19 vaccine. [6] [7] The vaccine Corbevax [8] /Bio E COVID-19 was expected to roll out in 2021 with 75 to 80 million doses manufactured per month; the production was expected to reach 1 billion doses by the end of 2022 under the Quad ...